• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Terveystalo

7.54 EUR

+2.59 %

12,252 following

TTALO

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+2.59 %
-3.95 %
-21.13 %
-22.90 %
-19.62 %
-36.21 %
-11.29 %
-35.99 %
-24.60 %

Terveystalo operates in the healthcare sector. The company offers services and solutions such as surveys and examinations, training and coaching, rehabilitation, and health and fitness mapping. Its customers include small and medium-sized corporate customers, as well as public sector players. The head office is located in Helsinki.

Read more
Market cap
957.86M EUR
Turnover
1.96M EUR
P/E (adj.) (26e)
10.63
EV/EBIT (adj.) (26e)
11.32
P/B (26e)
1.65
EV/S (26e)
1.24
Dividend yield-% (26e)
4.24 %
Coverage
Recommendation
Reduce
Target price
7.90 EUR
Updated
08.06.2026
Disclaimer
Roni Peuranheimo
Roni Peuranheimo

Analyst

Latest research

Latest analysis report

Released: 09.06.2026

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
If the FCCA (KKV) did its job at all, this deal wouldn’t go through. This is a rather massive acquisition in a highly concentrated industry, and such a deal should not be allowed to pass on the grounds of a significant reduction in competition. I consider it more likely that the ...
6/9/2026, 6:37 PM
by JNivala
25
Terveystalo’s CEO doesn’t understand anything about clinical reality and tries to cover up this ignorance by using plenty of foreign loanwords and surrounding themselves with commercially-oriented representatives who are just as clinically incompetent. Relations with the practitioners...
6/10/2026, 8:02 PM
16
Terveystalo certainly has an exceptionally poor feel for its market. One moment we’re in a wave of sorrow, and the next we’re euphorically hyping a “profitability turnaround.” I don’t know if it’s a characteristic of the market or a problem Terveystalo has created for itself, but...
6/10/2026, 6:42 AM
by lokomotiivi
14
Grow or die. Terveystalo is essentially operating as it should. Without taking a stance on the current management, doctors or priests should not lead anything related to business. Of course, their opinions can be consulted.
6/11/2026, 6:53 AM
by TitoK
11
These reflections on new diagnostics performed via the eyes are definitely not something for this decade; we’re talking more about this potentially happening in the 2030s or 2040s. It’s really not worth expecting Terveystalo to generate any euros from that perspective in the coming...
6/10/2026, 7:31 PM
by JNivala
11
The report feels quite bearish. I certainly understand that risks are always present in M&A, but to my eye, the perspective seems rather cautious following such a major acquisition. If and when the deal goes through, wouldn’t the acquisition of Silmäasema fundamentally be a significant...
6/9/2026, 1:07 PM
by Mehukasta
11
Business professionals are required for that, not clinicians, so that aspect is on the right track; whether the right professionals were chosen is another matter. In Europe, it has long been common for even hospitals to be run by business people, and judging by the state of public...
6/12/2026, 5:41 AM
by Anderssonni
8
Read more on our forum
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.7
2026

Interim report Q2'26

7.10
2026

Half year dividend

21.10
2026

Interim report Q3'26

Terveystalo, Webcast, Q2'26
Webcast7/17/2026, 7:30 AM

Terveystalo, Webcast, Q2'26

Terveystalo
Regulatory press release6/16/2026, 2:12 PM

Terveystalo Plc increases bond maturing in 2028 by EUR 29.9 million and has submitted a listing application for the tap issue

Terveystalo
Terveystalo: Optikeren søger yderligere styrker
Research6/9/2026, 4:00 AM by
Roni Peuranheimo

Terveystalo: Optikeren søger yderligere styrker

Med opkøbene af Silmäasema og Hohde er Terveystalo ved at bevæge sig fra en stabil udbyttebetaler til en mere vækstorienteret retning.

Terveystalo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Terveystalo’s press conference on the Silmäasema acquisition
Webcast6/8/2026, 9:00 AM

Terveystalo’s press conference on the Silmäasema acquisition

A briefing for investors and analysts will be held on 8 June 2026 at 12:00 noon EEST.

Terveystalo
Terveystalo køber Silmäasema og opdaterer sin strategi
Analyst Comment6/8/2026, 6:27 AM by
Roni Peuranheimo

Terveystalo køber Silmäasema og opdaterer sin strategi

Der er tale om et transformativt opkøb for Terveystalo.

Terveystalo
Regulatory press release6/8/2026, 5:10 AM

Terveystalo Oyj: Notice of Extraordinary General Meeting of Terveystalo Plc

Terveystalo
Regulatory press release6/8/2026, 5:05 AM

Inside information: Terveystalo to acquire Silmäasema to accelerate growth and increase presence in the growing eye care market

Terveystalo
Regulatory press release6/8/2026, 5:00 AM

Inside information: Terveystalo updates its strategic focus, financial targets for the medium term and dividend policy

Terveystalo
Terveystalo afslutter restruktureringsforhandlinger
Analyst Comment5/28/2026, 4:53 AM by
Roni Peuranheimo

Terveystalo afslutter restruktureringsforhandlinger

Restruktureringsforhandlingerne fører til personalereduktioner samt omfattende fyringer.

Terveystalo
Terveystalo Q1'26: Historisk svag efterspørgsel tynger alle linjer
Research4/27/2026, 5:00 AM by
Roni Peuranheimo

Terveystalo Q1'26: Historisk svag efterspørgsel tynger alle linjer

Terveystalos regnskabsmeddelelse for 1. kvartal lå markant under både vores og konsensus' forventninger, da efterspørgselssituationen på markedet for private sundhedsydelser var historisk svag.

Terveystalo
Terveystalo, Webcast, Q1'26
Webcast4/24/2026, 7:30 AM

Terveystalo, Webcast, Q1'26

Terveystalo
Regulatory press release4/24/2026, 6:00 AM

Terveystalo Oyj: Terveystalo Group Interim Report January-March 2026: Despite the difficult demand environment, profitability remained at a good level

Terveystalo
Terveystalo indleder restruktureringsforhandlinger på grund af svag efterspørgsel
Analyst Comment4/22/2026, 4:00 AM by
Roni Peuranheimo

Terveystalo indleder restruktureringsforhandlinger på grund af svag efterspørgsel

Behovet for at reducere indikerer, at efterspørgslen efter sundhedsydelser ikke vil stige i den nærmeste fremtid.

Terveystalo
Terveystalo Q1'26 preview: Efterspørgselsudsigterne er udfordrende
Research4/17/2026, 5:00 AM by
Roni Peuranheimo

Terveystalo Q1'26 preview: Efterspørgselsudsigterne er udfordrende

Efterspørgslen på det private sundhedsmarked har været svag i begyndelsen af året baseret på flere offentlige datapunkter.

Terveystalo
Analyst Comment4/1/2026, 5:14 AM by
Roni Peuranheimo

Mehiläinen fortsatte sin stærke opkøbsdrevne vækst i 2025

Mehiläinen fremskyndede sin vækst markant sidste år, men hovedsageligt ikke-organisk.

TerveystaloPihlajalinna
Regulatory press release3/31/2026, 6:00 AM

Terveystalo Oyj: Changes in Terveystalo's Executive Team

Terveystalo
Regulatory press release3/24/2026, 12:00 PM

Terveystalo Oyj: Resolutions of the organising meeting of Terveystalo's Board of Directors

Terveystalo
Regulatory press release3/24/2026, 10:30 AM

Terveystalo Oyj: Terveystalo Plc: Resolutions of Annual General Meeting

Terveystalo
Regulatory press release3/11/2026, 10:00 AM

Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Iho

Terveystalo
Regulatory press release3/11/2026, 10:00 AM

Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Saviharju

Terveystalo